Sofinnova wraps up crossover fund at $540m
Sofinnova Partners, a European life sciences venture firm, has closed its crossover fund at $540 million.
3 March 2021•3 mins read
Sofinnova Partners, a European life sciences venture firm, has closed its crossover fund at $540 million.